Connect with us

Politics

DA seeks answers on R215 million spent on unproven COVID-19 medication

Published on

The DA has released a statement calling for Nosiviwe Mapisa-Nqakula to set the record straight on allegations that the SANDF spent an estimated R215 million on unproven COVID-19 medication.  

The Democratic Alliance (DA) released a statement on Thursday, 22 October 2020, calling on Minister of Defence and Military Veterans, Nosiviwe Mapisa-Nqakula to account for alleged irregular expenditure. This follows claims that the South African National Defence Force (SANDF) spent an estimated R215 million on unproven COVID-19 medication.

The statement further claimed, “What is more, a letter from South African Military Health Services (SAMHS) seems to indicate that the order for the Heberon Alpha R 2B, also known as Interferon, did not come from them and, as such, has yet to be accepted as stock as this particular medication is not registered for use by the South African Health Products Regulatory Authority (SAHPRA).”

In addition to asking the minister and department to address the allegations, the DA has also vowed to pursue an investigation or seek answers on the allegations. The party will raise the matter when the Auditor-General appears before the Portfolio Committee on Defence and Military Veterans to report on the department’s COVID-19 spending.

Read the full statement below.

Sabelo Makhubo
[email protected]

Trending

Copyright © 2020 Political Analysis South Africa, a Paulton Media (Pty) Ltd. publication.

error: Copyrighted Content